Teligent, Inc. (NASDAQ:TLGT) Rating Lowered to Sell at BidaskClub

BidaskClub cut shares of Teligent, Inc. (NASDAQ:TLGT) from a hold rating to a sell rating in a research report sent to investors on Monday, July 24th.

Several other equities analysts have also recently issued reports on the company. Deutsche Bank AG reissued a hold rating and set a $9.00 target price (up from $8.00) on shares of Teligent in a research note on Monday, July 17th. Zacks Investment Research lowered Teligent from a hold rating to a sell rating in a research report on Thursday, July 6th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $9.25.

Shares of Teligent (NASDAQ TLGT) traded down 3.24% during trading on Monday, hitting $6.42. The company had a trading volume of 673,952 shares. The firm’s market capitalization is $342.77 million. The company’s 50 day moving average is $8.29 and its 200 day moving average is $8.00. Teligent has a 1-year low of $5.75 and a 1-year high of $9.54.

Teligent (NASDAQ:TLGT) last posted its earnings results on Tuesday, August 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.02 by $0.04. Teligent had a negative net margin of 11.36% and a positive return on equity of 1.49%. The business had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $20.11 million. During the same period last year, the firm posted $0.02 earnings per share. Teligent’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts anticipate that Teligent will post $0.12 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.thestockobserver.com/2017/08/12/teligent-inc-nasdaqtlgt-stock-rating-lowered-by-bidaskclub-updated-updated.html.

Large investors have recently added to or reduced their stakes in the stock. FMR LLC purchased a new stake in Teligent during the second quarter valued at $6,543,000. Russell Investments Group Ltd. raised its stake in Teligent by 124.1% in the second quarter. Russell Investments Group Ltd. now owns 1,043,046 shares of the company’s stock valued at $9,544,000 after buying an additional 577,635 shares in the last quarter. RK Capital Management LLC purchased a new stake in Teligent during the second quarter valued at $4,581,000. Vanguard Group Inc. raised its stake in Teligent by 10.4% in the first quarter. Vanguard Group Inc. now owns 1,976,891 shares of the company’s stock valued at $15,440,000 after buying an additional 185,624 shares in the last quarter. Finally, Timpani Capital Management LLC purchased a new stake in Teligent during the second quarter valued at $1,692,000. Institutional investors own 62.75% of the company’s stock.

About Teligent

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply